Bitrobius Genetics
Bitrobius Genetics is a pioneering company focused on revolutionizing gene therapy through innovative plasmid technology called Gentrafix™. Their mission is to end genetic diseases by developing advanced gene delivery systems and fostering collaborations for funding and partnerships.
Industries
biotechnology
health-care
medical
Nr. of Employees
small (1-50)
Products
Plasmid-based self-replicating gene-delivery system
A plasmid DNA delivery approach designed to express therapeutic proteins in target organs, enable plasmid replication, and promote spread to adjacent cells to extend therapeutic reach.
Plasmid-based self-replicating gene-delivery system
A plasmid DNA delivery approach designed to express therapeutic proteins in target organs, enable plasmid replication, and promote spread to adjacent cells to extend therapeutic reach.
Services
Collaborative gene therapy development partnerships
Partnerships and collaborations to co-develop gene-therapy programs, explore funding opportunities, and provide access to platform capabilities.
Collaborative gene therapy development partnerships
Partnerships and collaborations to co-develop gene-therapy programs, explore funding opportunities, and provide access to platform capabilities.
Expertise Areas
- Gene therapy development
- Nucleic acid therapeutics
- Protein engineering
- Preclinical disease modelling
Key Technologies
- Plasmid-based gene delivery
- CRISPR/Cas gene editing
- Viral vectors for genome editing
- Modified RNA therapeutics